{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:03:01Z","timestamp":1740027781206,"version":"3.37.3"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2007957"],"award-info":[{"award-number":["2007957"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Treatment\u2010related premature ovarian insufficiency (POI) can result in early\u2010onset menopause and infertility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To assess the prevalence of goserelin use for POI prevention in women with cancer since it was listed by the Australian Pharmaceutical Benefits Scheme in 2018 for this indication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included women aged 18\u201345\u2009years who received curative\u2010intent alkylating chemotherapy for a malignancy between August 2020 and December 2022 at the Peter MacCallum Cancer Centre. The co\u2010primary end\u2010points were (i) documentation of a discussion with the patient regarding goserelin for POI prevention and (ii) prescription of goserelin for POI prevention prior to chemotherapy commencement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty\u2010six patients were eligible. Fifty patients (76%) had a documented discussion regarding goserelin for POI prevention and 53 patients (80%) were prescribed goserelin for POI prevention. Nulliparous women were more likely to have a discussion regarding goserelin (<jats:italic>P<\/jats:italic> =\u20090.004). Younger women, nulliparous women and those referred to a fertility service were more likely to have been prescribed goserelin for POI prevention (<jats:italic>P<\/jats:italic> =\u20090.003, <jats:italic>P<\/jats:italic> =\u20090.001 and <jats:italic>P<\/jats:italic> =\u20090.002 respectively). Twenty\u2010one of 53 patients (40%) who received goserelin had the first dose administered \u22657\u2009days before chemotherapy commencement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>One\u2010quarter of eligible patients did not have a documented discussion regarding goserelin, despite the negative consequences of POI. Efforts are needed to increase the discussion and use of goserelin in all premenopausal women regardless of their fertility interests and to ensure timely administration in those who choose to receive it.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.16564","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T07:29:37Z","timestamp":1730878177000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uptake of gonadotrophin\u2010releasing hormone agonists for prevention of premature ovarian insufficiency in women undergoing chemotherapy: an <scp>Australian<\/scp> single\u2010centre study"],"prefix":"10.1111","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-0250","authenticated-orcid":false,"given":"Felicity C.","family":"Martin","sequence":"first","affiliation":[{"name":"Department of Medical Oncology Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly\u2010Anne","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"},{"name":"Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Haematology Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimity","family":"Paul","sequence":"additional","affiliation":[{"name":"VCCC Consumer, Victorian Comprehensive Cancer Centre  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Obstetric Medicine Royal Women's Hospital  Melbourne Victoria Australia"},{"name":"Department of Medicine Royal Melbourne Hospital, University of Melbourne  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genia","family":"Rozen","sequence":"additional","affiliation":[{"name":"Department of Obstetric Medicine Royal Women's Hospital  Melbourne Victoria Australia"},{"name":"Department of Obstetrics and Gynaecology University of Melbourne  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharyn","family":"Stern","sequence":"additional","affiliation":[{"name":"Department of Obstetric Medicine Royal Women's Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing (Sophia)","family":"Xie","sequence":"additional","affiliation":[{"name":"Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5077-6814","authenticated-orcid":false,"given":"Wanda","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60355-8"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7689"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr541"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp394"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.8877"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2019.07.001"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.1914"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.007"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv221"},{"volume-title":"Fertility Preservation for People with Cancer","year":"2021","author":"COSA Fertility Preservation Guidelines Working Group","key":"e_1_2_7_11_1"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz173"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy310"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt345"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy080"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz062"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590701582406"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.3969"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30500-X"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja18.00190"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz027"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0176"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.0858"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy185"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18934"},{"key":"e_1_2_7_26_1","unstructured":"Australian Government Department of Health.The Pharmaceutical Benefits Scheme. Goserelin. Available from URL:https:\/\/www.pbs.gov.au\/medicine\/item\/1454M"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab213"},{"key":"e_1_2_7_28_1","unstructured":"Australian Bureau of Statistics.Socio\u2010Economic Indexes for Areas. 2016. Available from URL:https:\/\/www.abs.gov.au\/websitedbs\/censushome.nsf\/home\/seifa"},{"key":"e_1_2_7_29_1","unstructured":"eviQ Cancer Treatments Online.BRCA1 or BRCA2 \u2013 Risk Management (Female). 2021. Available from URL:https:\/\/www.eviq.org.au\/cancer-genetics\/adult\/risk-management\/3814-brca1-or-brca2-risk-management-female#references"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2758-x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.196"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.159"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.12.001"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080444"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1530\/RAF-22-0123"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-3991(02)00174-X"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-011-0328-8"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.0250"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmy038"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2020.23.e33"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1071\/AH22295"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2010.000017"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.16564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:55:48Z","timestamp":1739940948000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.16564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/imj.16564"],"URL":"https:\/\/doi.org\/10.1111\/imj.16564","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"type":"print","value":"1444-0903"},{"type":"electronic","value":"1445-5994"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"2024-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}